Marico Limited v. Adani Wilmar Ltd

In the fiercely competitive world of edible oils, brands don't just sell products—they sell health, wellness, and trust. So what happens when one company believes a rival's advertisement crosses the line from clever marketing into outright disparagement? The Delhi High Court was asked to step into exactly this kind of commercial battlefield, and its response offers a masterclass in how courts balance free advertising speech against the protection of established brands.

Marico Limited, the company behind the well-known 'Saffola' brand of edible oils, found itself watching its competitor's advertisements with growing concern. Adani Wilmar Ltd, the maker of 'Fortune' edible oils, had rolled out a campaign that Marico believed was taking direct aim at Saffola's reputation. At the heart of Marico's grievance was the claim that Adani Wilmar's 'Fortune' advertisements were making health-related assertions that disparaged Saffola and misled consumers. Believing the damage to its brand was immediate and ongoing, Marico approached the Delhi High Court seeking an interim injunction—a court order that would halt the broadcast of the rival ads while the underlying dispute was still being decided.

Marico's argument was rooted in the idea that the 'Fortune' advertisements contained false health claims that unfairly targeted and undermined the credibility of the 'Saffola' brand. From Marico's perspective, these were not mere puffery or harmless marketing exaggerations—they were unsubstantiated assertions that could mislead consumers and erode years of brand-building. Marico pushed for the court to step in and stop the campaign in its tracks. Adani Wilmar, on the other hand, defended its advertisements as legitimate competitive messaging. The core legal friction was this: should the court intervene in an active advertising campaign based on disputed claims, or should it allow the marketplace of ideas—and products—to function until a full trial could sort out the truth?

The Delhi High Court declined to grant Marico the interim injunction it sought, and the 'Fortune' advertisements were allowed to continue airing pending final adjudication. The court's reasoning rested on a crucial principle: advertisers must be given reasonable latitude in how they craft their messages. The bench emphasized that courts should not adopt a hyper-technical view of advertising claims unless those claims are shown to be entirely unsubstantiated. In other words, the bar for pulling a competitor's ad off the air is high—a plaintiff must demonstrate that the rival's claims are totally baseless, not merely debatable or exaggerated. Because Marico had not cleared that high bar at the interim stage, the court ruled in favor of Adani Wilmar, allowing the campaign to proceed.

For founders and brand leaders, this case is a sobering reminder that courts are reluctant to muzzle a competitor's marketing voice during the heat of a dispute. If you plan to challenge a rival's advertising on grounds of disparagement or false claims, be prepared to show that those claims are completely unsubstantiated—not just questionable or aggressive. Comparative advertising is a legitimate tool in competitive markets, and the legal system grants advertisers considerable creative space. The practical lesson: invest in rigorous substantiation for your own health and product claims, document your evidence meticulously, and understand that winning an interim injunction against a rival's ad campaign is an uphill battle unless the opposing claims are demonstrably groundless.